Cargando…

Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice

The formation of amyloid fibrils by human islet amyloid polypeptide protein (hIAPP) has been implicated in pancreas dysfunction and diabetes. However, efficient treatment options to reduce amyloid fibrils in vivo are still lacking. Therefore, we tested the effect of epigallocatechin gallate (EGCG) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franko, Andras, Rodriguez Camargo, Diana C., Böddrich, Annett, Garg, Divita, Rodriguez Camargo, Andres, Rathkolb, Birgit, Janik, Dirk, Aichler, Michaela, Feuchtinger, Annette, Neff, Frauke, Fuchs, Helmut, Wanker, Erich E., Reif, Bernd, Häring, Hans-Ulrich, Peter, Andreas, Hrabě de Angelis, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773570/ https://www.ncbi.nlm.nih.gov/pubmed/29348618 http://dx.doi.org/10.1038/s41598-017-18807-8

Ejemplares similares

The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2017)

Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020)

Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate
por: Rodriguez Camargo, Diana C, et al.
Publicado: (2017)

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly
por: Xu, Yong, et al.
Publicado: (2022)

Diabetes Drug Discovery: hIAPP(1–37) Polymorphic Amyloid Structures as Novel Therapeutic Targets
por: Fernández-Gómez, Isaac, et al.
Publicado: (2018)

Conformationally restricted short peptides inhibit human islet amyloid polypeptide (hIAPP) fibrillization
por: Mishra, Aseem, et al.
Publicado: (2013)

A Novel Pentapeptide Inhibitor Reduces Amyloid Deposit Formation by Direct Interaction with hIAPP
por: Shi, Yue, et al.
Publicado: (2019)

β-Hairpin Peptide Mimics Decrease Human Islet Amyloid Polypeptide (hIAPP) Aggregation
por: Lesma, Jacopo, et al.
Publicado: (2021)

Chitosan Oligosaccharides Attenuate Amyloid Formation of hIAPP and Protect Pancreatic β-Cells from Cytotoxicity
por: Meng, Qin-Yu, et al.
Publicado: (2020)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation
por: Mo, Yuxiang, et al.
Publicado: (2016)

Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early β-cell damage in obesity and diabetes
por: Altamirano-Bustamante, Nelly F., et al.
Publicado: (2020)

Effect of DNA Origami Nanostructures on hIAPP Aggregation
por: Hanke, Marcel, et al.
Publicado: (2020)

Exploring the Influence of EGCG on the β-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP(1–37)) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation
por: Wang, Qianqian, et al.
Publicado: (2014)

The Green Tea Polyphenol Epigallocatechin-Gallate (EGCG) Interferes with Microcin E492 Amyloid Formation
por: Aguilera, Paulina, et al.
Publicado: (2023)

Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation
por: Jia, Yan, et al.
Publicado: (2013)

Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity
por: Paul, Ashim, et al.
Publicado: (2020)

Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus
por: Höppener, J. W. M., et al.
Publicado: (2008)

Effect of Terminal Modifications on the Adsorption and Assembly of hIAPP(20–29)
por: Hajiraissi, Roozbeh, et al.
Publicado: (2019)

Factors That Contribute to hIAPP Amyloidosis in Type 2 Diabetes Mellitus
por: Sevcuka, Adriana, et al.
Publicado: (2022)

Human Islet Amyloid Polypeptide (hIAPP) Protofibril‐Specific Antibodies for Detection and Treatment of Type 2 Diabetes (Adv. Sci. 34/2022)
por: Bortoletto, Angelina S., et al.
Publicado: (2022)

Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus
por: Altamirano-Bustamante, Myriam M., et al.
Publicado: (2019)

Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action
por: Niu, Zheng, et al.
Publicado: (2020)

Pancreatic β cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics
por: Hernández, Miriam García, et al.
Publicado: (2018)

Nanoscale Surface Topography Modulates hIAPP Aggregation Pathways at Solid–Liquid Interfaces
por: Hanke, Marcel, et al.
Publicado: (2021)

The Effect of Calcium Ions on hIAPP Channel Activity: Possible Implications in T2DM
por: Meleleo, Daniela, et al.
Publicado: (2023)

Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
por: Wasana Jayaweera, Sanduni, et al.
Publicado: (2021)

Expression of wild‐type and mutant S20G hIAPP in physiologic knock‐in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance
por: Hiddinga, Henry J, et al.
Publicado: (2011)

Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity
por: Krotee, Pascal, et al.
Publicado: (2017)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective
por: Hassan, Shahab, et al.
Publicado: (2022)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Antibacterial Activity of Epigallocatechin Gallate (EGCG) against Shigella flexneri
por: Zhang, Yini, et al.
Publicado: (2023)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
por: Zhang, Qiang, et al.
Publicado: (2023)

Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice
por: Franko, Andras, et al.
Publicado: (2017)

Metastable intermediate during hIAPP aggregation catalyzed by membranes as detected with 2D IR spectroscopy
por: Dicke, Sidney S., et al.
Publicado: (2022)

General Amyloid Inhibitors? A Critical Examination of the Inhibition of IAPP Amyloid Formation by Inositol Stereoisomers
por: Wang, Hui, et al.
Publicado: (2014)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity
por: Zelus, Casey, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7apjfu85v08gqo71tc30psevlo